Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 304

1.

BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous Carcinoma.

Byrne T, Nelson L, Beirne JP, Sharpe D, Quinn JE, McCluggage WG, Robson T, Furlong F.

Int J Gynecol Cancer. 2018 Mar;28(3):472-478. doi: 10.1097/IGC.0000000000001214.

PMID:
29465507
2.

Approximating the Shifted Hartree-Exchange-Correlation Potential in Direct Energy Kohn-Sham Theory.

Sharpe DJ, Levy M, Tozer DJ.

J Chem Theory Comput. 2018 Feb 13;14(2):684-692. doi: 10.1021/acs.jctc.7b01060. Epub 2018 Jan 24.

PMID:
29298061
3.

Understanding forensic psychiatry in healthcare practices and collaboration between legal nurse consultants and physicians.

Sharpe DK, Hall JK, Ochije S, Bailey RK.

Med Leg J. 2018 Mar;86(1):32-35. doi: 10.1177/0025817217740299. Epub 2017 Dec 5.

PMID:
29206080
4.

Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life.

Miranda BH, Charlesworth MR, Tobin DJ, Sharpe DT, Randall VA.

FASEB J. 2018 Feb;32(2):795-806. doi: 10.1096/fj.201700260RR. Epub 2018 Jan 4.

PMID:
29046359
5.

GATA2 regulates the erythropoietin receptor in t(12;21) ALL.

Gaine ME, Sharpe DJ, Smith JS, Colyer HAA, Hodges VM, Lappin TR, Mills KI.

Oncotarget. 2017 Aug 2;8(39):66061-66074. doi: 10.18632/oncotarget.19792. eCollection 2017 Sep 12.

6.

Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.

Gravante G, Stephenson JA, Elshaer M, Osman A, Vasanthan S, Mullineux JH, Gani MAD, Sharpe D, Yeung J, Norwood M, Miller A, Boyle K, Hemingway D.

J Surg Oncol. 2017 Sep 10. doi: 10.1002/jso.24794. [Epub ahead of print]

PMID:
28891266
7.

Mental Health Care Disparities Now and in the Future.

Bailey R, Sharpe D, Kwiatkowski T, Watson S, Dexter Samuels A, Hall J.

J Racial Ethn Health Disparities. 2017 Jun 20. doi: 10.1007/s40615-017-0377-6. [Epub ahead of print]

PMID:
28634875
8.

Assessing the Factor Structure of the Integrative Hope Scale.

Sharpe D, McElheran J, Whelton WJ.

Assessment. 2017 Mar 1:1073191117700269. doi: 10.1177/1073191117700269. [Epub ahead of print]

PMID:
28355891
9.

Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome.

Mason-Suares H, Toledo D, Gekas J, Lafferty KA, Meeks N, Pacheco MC, Sharpe D, Mullen TE, Lebo MS.

Eur J Hum Genet. 2017 Apr;25(4):509-511. doi: 10.1038/ejhg.2016.202. Epub 2017 Jan 18.

PMID:
28098151
10.

Tropical fish community does not recover 45 years after predator introduction.

Sharpe DM, De León LF, González R, Torchin ME.

Ecology. 2017 Feb;98(2):412-424. doi: 10.1002/ecy.1648. Epub 2017 Jan 12.

PMID:
27861787
11.

Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors.

Gravante G, Hemingway D, Stephenson JA, Sharpe D, Osman A, Haines M, Pirjamali V, Sorge R, Yeung JM, Norwood M, Miller A, Boyle K.

J Surg Oncol. 2016 Oct;114(5):642-648. doi: 10.1002/jso.24360. Epub 2016 Jul 7.

PMID:
27383398
12.

Facilitating a Major Staffing Transition in a State Psychiatric Hospital With Changes to Nursing Orientation.

Birnbaum S, Sperber-Weiss D, Dimitrios T, Eckel D Jr, Monroy-Miller C, Monroe JJ, Friedman R, Ologbosele M, Epo G, Sharpe D, Zarski Y.

J Am Psychiatr Nurses Assoc. 2017 Jan/Feb;23(1):66-72. doi: 10.1177/1078390316667529. Epub 2016 Sep 20.

PMID:
27566623
13.

Coping with Multiple Sclerosis Scale: Reconsideration of the Factorial Structure.

Parkerson HA, Kehler MD, Sharpe D, Hadjistavropoulos HD.

Int J MS Care. 2016 Jul-Aug;18(4):192-200. doi: 10.7224/1537-2073.2015-031.

14.

Older Adults and the Fear of Death: The Protective Function of Generativity.

Major RJ, Whelton WJ, Schimel J, Sharpe D.

Can J Aging. 2016 Jun;35(2):261-72. doi: 10.1017/S0714980816000143. Epub 2016 Apr 27.

PMID:
27118066
15.

Radon testing in rapid access lung clinics: an opportunity for secondary prevention.

Smyth R, Long S, Wiseman E, Sharpe D, Breen D, O'Regan A.

Ir J Med Sci. 2017 May;186(2):485-487. doi: 10.1007/s11845-016-1448-0. Epub 2016 Mar 30.

PMID:
27083463
16.

Circumferential resection margins and perineal complications after neoadjuvant long-course chemoradiotherapy followed by extralevator abdominoperineal excision of the rectum: Five years of activity at a single institution.

Gravante G, Miah A, Mann CD, Stephenson JA, Gani MA, Sharpe D, Norwood M, Boyle K, Miller A, Hemingway D.

J Surg Oncol. 2016 Jul;114(1):86-90. doi: 10.1002/jso.24257. Epub 2016 Apr 13.

PMID:
27076410
17.

Low Predictability of Colour Polymorphism in Introduced Guppy (Poecilia reticulata) Populations in Panama.

Martínez C, Chavarría C, Sharpe DM, De León LF.

PLoS One. 2016 Feb 10;11(2):e0148040. doi: 10.1371/journal.pone.0148040. eCollection 2016.

18.

Little evidence for morphological change in a resilient endemic species following the introduction of a novel predator.

Sharpe DM, Langerhans RB, Low-Décarie E, Chapman LJ.

J Evol Biol. 2015 Nov;28(11):2054-67. doi: 10.1111/jeb.12720. Epub 2015 Sep 7.

19.

The Chemical Validation and Standardization Platform (CVSP): large-scale automated validation of chemical structure datasets.

Karapetyan K, Batchelor C, Sharpe D, Tkachenko V, Williams AJ.

J Cheminform. 2015 Jun 19;7:30. doi: 10.1186/s13321-015-0072-8. eCollection 2015.

20.

Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.

Weiner-Gorzel K, Dempsey E, Milewska M, McGoldrick A, Toh V, Walsh A, Lindsay S, Gubbins L, Cannon A, Sharpe D, O'Sullivan J, Murphy M, Madden SF, Kell M, McCann A, Furlong F.

Cancer Med. 2015 May;4(5):745-58. doi: 10.1002/cam4.409. Epub 2015 Feb 15.

21.

Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma.

Sabado RL, Pavlick A, Gnjatic S, Cruz CM, Vengco I, Hasan F, Spadaccia M, Darvishian F, Chiriboga L, Holman RM, Escalon J, Muren C, Escano C, Yepes E, Sharpe D, Vasilakos JP, Rolnitzsky L, Goldberg J, Mandeli J, Adams S, Jungbluth A, Pan L, Venhaus R, Ott PA, Bhardwaj N.

Cancer Immunol Res. 2015 Mar;3(3):278-287. doi: 10.1158/2326-6066.CIR-14-0202. Epub 2015 Jan 29.

22.

POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer.

Sharpe DJ, Orr KS, Moran M, White SJ, McQuaid S, Lappin TR, Thompson A, James JA.

Oncotarget. 2014 Sep 30;5(18):8803-15.

23.

Sensitivity and specificity of the empirical lymphocyte genome sensitivity (LGS) assay: implications for improving cancer diagnostics.

Anderson D, Najafzadeh M, Gopalan R, Ghaderi N, Scally AJ, Britland ST, Jacobs BK, Reynolds PD, Davies J, Wright AL, Al-Ghazal S, Sharpe D, Denyer MC.

FASEB J. 2014 Oct;28(10):4563-70. doi: 10.1096/fj.14-254748. Epub 2014 Jul 25.

PMID:
25063845
24.

Prognostic value of baseline FDG uptake on PET-CT in esophageal carcinoma.

Al-Taan OS, Eltweri A, Sharpe D, Rodgers PM, Ubhi SS, Bowrey DJ.

World J Gastrointest Oncol. 2014 May 15;6(5):139-44. doi: 10.4251/wjgo.v6.i5.139.

25.

Synthesis and properties of chemiluminescent acridinium ester labels with fluorous tags.

Natrajan A, Wen D, Sharpe D.

Org Biomol Chem. 2014 Jun 21;12(23):3887-901. doi: 10.1039/c4ob00456f.

PMID:
24788381
26.

Fine-scale genetic response to landscape change in a gliding mammal.

Goldingay RL, Harrisson KA, Taylor AC, Ball TM, Sharpe DJ, Taylor BD.

PLoS One. 2013 Dec 26;8(12):e80383. doi: 10.1371/journal.pone.0080383. eCollection 2013.

27.

The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia.

Suresh S, McCallum L, Crawford LJ, Lu WH, Sharpe DJ, Irvine AE.

J Pathol. 2013 Nov;231(3):378-87.

28.

Exercise therapy for improved neck muscle function in helicopter aircrew.

Salmon DM, Harrison MF, Sharpe D, Candow D, Albert WJ, Neary JP.

Aviat Space Environ Med. 2013 Oct;84(10):1046-54.

PMID:
24261057
29.

Psychometric evaluation and refinement of the Pain Response Preference Questionnaire.

McWilliams LA, Kowal J, Sharpe D, Dick BD.

Pain Res Manag. 2014 Jan-Feb;19(1):42-8. Epub 2013 Nov 7.

30.

Bone morphogenetic protein signaling suppresses wound-induced skin repair by inhibiting keratinocyte proliferation and migration.

Lewis CJ, Mardaryev AN, Poterlowicz K, Sharova TY, Aziz A, Sharpe DT, Botchkareva NV, Sharov AA.

J Invest Dermatol. 2014 Mar;134(3):827-837. doi: 10.1038/jid.2013.419. Epub 2013 Oct 14.

31.

Why the resistance to statistical innovations? Bridging the communication gap.

Sharpe D.

Psychol Methods. 2013 Dec;18(4):572-82. doi: 10.1037/a0034177. Epub 2013 Sep 30.

PMID:
24079924
32.

Practices of anesthesiologists to alleviate anxiety in children and adolescents in Canada.

Wright KD, Finley GA, Lee DJ, Raazi M, Sharpe D.

Can J Anaesth. 2013 Nov;60(11):1161-2. doi: 10.1007/s12630-013-0018-4. Epub 2013 Sep 14. No abstract available.

PMID:
24037746
33.

AKT in stromal fibroblasts controls invasion of epithelial cells.

Cichon AC, Pickard A, McDade SS, Sharpe DJ, Moran M, James JA, McCance DJ.

Oncotarget. 2013 Jul;4(7):1103-16.

34.

Targeted next generation sequencing in SPAST-negative hereditary spastic paraplegia.

Kumar KR, Blair NF, Vandebona H, Liang C, Ng K, Sharpe DM, Grünewald A, Gölnitz U, Saviouk V, Rolfs A, Klein C, Sue CM.

J Neurol. 2013 Oct;260(10):2516-22. doi: 10.1007/s00415-013-7008-x. Epub 2013 Jun 28.

PMID:
23812641
35.

Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia.

Ramsey JM, Kettyle LM, Sharpe DJ, Mulgrew NM, Dickson GJ, Bijl JJ, Austin P, Mayotte N, Cellot S, Lappin TR, Zhang SD, Mills KI, Krosl J, Sauvageau G, Thompson A.

Stem Cells. 2013 Jul;31(7):1434-45. doi: 10.1002/stem.1398.

36.

Multiple Symmetrical Lipomatosis--a mitochondrial disorder of brown fat.

Plummer C, Spring PJ, Marotta R, Chin J, Taylor G, Sharpe D, Athanasou NA, Thyagarajan D, Berkovic SF.

Mitochondrion. 2013 Jul;13(4):269-76. doi: 10.1016/j.mito.2013.03.003. Epub 2013 Mar 20.

PMID:
23524250
37.

A culturally targeted self-management program for African Americans with type 2 diabetes mellitus.

Collins-McNeil J, Edwards CL, Batch BC, Benbow D, McDougald CS, Sharpe D.

Can J Nurs Res. 2012 Dec;44(4):126-41.

38.

Synthesis and properties of differently charged chemiluminescent acridinium ester labels.

Natrajan A, Sharpe D.

Org Biomol Chem. 2013 Feb 14;11(6):1026-39. doi: 10.1039/c2ob27190g. Epub 2013 Jan 7.

PMID:
23296263
39.

The Short Health Anxiety Inventory: a systematic review and meta-analysis.

Alberts NM, Hadjistavropoulos HD, Jones SL, Sharpe D.

J Anxiety Disord. 2013 Jan;27(1):68-78. doi: 10.1016/j.janxdis.2012.10.009. Epub 2012 Nov 9. Review.

PMID:
23247202
40.

Life history change in response to fishing and an introduced predator in the East African cyprinid Rastrineobola argentea.

Sharpe DM, Wandera SB, Chapman LJ.

Evol Appl. 2012 Nov;5(7):677-93. doi: 10.1111/j.1752-4571.2012.00245.x.

41.

Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes.

del Rey M, O'Hagan K, Dellett M, Aibar S, Colyer HA, Alonso ME, Díez-Campelo M, Armstrong RN, Sharpe DJ, Gutiérrez NC, García JL, De Las Rivas J, Mills KI, Hernández-Rivas JM.

Leukemia. 2013 Mar;27(3):610-8. doi: 10.1038/leu.2012.253. Epub 2012 Aug 31.

PMID:
22936014
42.

The reassurance questionnaire: comparison of the latent structure in university, community, and medical samples.

Pugh NE, Hadjistavropoulos HD, Sharpe D.

Psychol Health Med. 2013;18(1):117-24. doi: 10.1080/13548506.2012.668196. Epub 2012 Apr 18.

PMID:
22512670
43.

Chemiluminescence from alkoxy-substituted acridinium dimethylphenyl ester labels.

Natrajan A, Sharpe D, Wen D.

Org Biomol Chem. 2012 May 7;10(17):3432-47. doi: 10.1039/c2ob00022a. Epub 2012 Mar 23.

PMID:
22441905
44.

Aging workforce: Retaining valuable nurses.

Collins-McNeil J, Sharpe D, Benbow D.

Nurs Manage. 2012 Mar;43(3):50-1. doi: 10.1097/01.NUMA.0000412228.68794.fa. No abstract available.

PMID:
22377607
45.

Detection and analysis of DNA methylation by pyrosequencing.

Colyer HA, Armstrong RN, Sharpe DJ, Mills KI.

Methods Mol Biol. 2012;863:281-92. doi: 10.1007/978-1-61779-612-8_17.

PMID:
22359300
46.

Zwitterionic reagents for labeling, cross-linking and improving the performance of chemiluminescent immunoassays.

Natrajan A, Sharpe D, Wen D.

Org Biomol Chem. 2012 Mar 7;10(9):1883-95. doi: 10.1039/c2ob06807a. Epub 2012 Jan 25.

PMID:
22278720
47.

Effect of surfactants on the chemiluminescence of acridinium dimethylphenyl ester labels and their conjugates.

Natrajan A, Sharpe D, Wen D.

Org Biomol Chem. 2011 Jul 21;9(14):5092-103. doi: 10.1039/c1ob05543g. Epub 2011 May 26.

PMID:
21614398
48.

Core cognitions related to health anxiety in self-reported medical and non-medical samples.

Hadjistavropoulos HD, Janzen JA, Kehler MD, Leclerc JA, Sharpe D, Bourgault-Fagnou MD.

J Behav Med. 2012 Apr;35(2):167-78. doi: 10.1007/s10865-011-9339-3. Epub 2011 Apr 13.

PMID:
21487723
49.

Health anxiety: comparison of the latent structure in medical and non-medical samples.

Alberts NM, Sharpe D, Kehler MD, Hadjistavropoulos HD.

J Anxiety Disord. 2011 May;25(4):612-4. doi: 10.1016/j.janxdis.2011.01.011. Epub 2011 Feb 26.

PMID:
21354766
50.

Estradiol effects on behavior and serum oxytocin are modified by social status and polymorphisms in the serotonin transporter gene in female rhesus monkeys.

Michopoulos V, Checchi M, Sharpe D, Wilson ME.

Horm Behav. 2011 Apr;59(4):528-35. doi: 10.1016/j.yhbeh.2011.02.002. Epub 2011 Feb 18.

Supplemental Content

Loading ...
Support Center